First Time Loading...
O

OmniAb Inc
NASDAQ:OABI

Watchlist Manager
OmniAb Inc
NASDAQ:OABI
Watchlist
Price: 4.48 USD 1.13% Market Closed
Updated: Apr 27, 2024

Wall Street
Price Targets

OABI Price Targets Summary
OmniAb Inc

Wall Street analysts forecast OABI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OABI is 10.2 USD with a low forecast of 7.07 USD and a high forecast of 13.65 USD.

Lowest
Price Target
7.07 USD
58% Upside
Average
Price Target
10.2 USD
128% Upside
Highest
Price Target
13.65 USD
205% Upside
OmniAb Inc Competitors:
Price Targets
086040
Biotoxtech Co Ltd
174% Upside
QSI
Quantum-Si Inc
70% Upside
1SXP
SCHOTT Pharma AG & Co KgaA
2% Downside
RVTY
Revvity Inc
26% Upside
ABSI
Absci Corp
92% Upside
688621
Beijing Sun-Novo Pharmaceutical Research Co Ltd
32% Upside
ICLR
ICON PLC
16% Upside
ORPH
Open Orphan PLC
199% Upside

Revenue
Forecast

Revenue Estimate
OmniAb Inc

For the last 3 years the compound annual growth rate for OmniAb Inc's revenue is 14%. The projected CAGR for the next 3 years is 32%.

14%
Past Growth
32%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
OmniAb Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
OmniAb Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OABI's stock price target?
Price Target
10.2 USD

According to Wall Street analysts, the average 1-year price target for OABI is 10.2 USD with a low forecast of 7.07 USD and a high forecast of 13.65 USD.

What is OmniAb Inc's Revenue forecast?
Projected CAGR
32%

For the last 3 years the compound annual growth rate for OmniAb Inc's revenue is 14%. The projected CAGR for the next 3 years is 32%.